-
ZIF-8–PEI Systems for mRNA Delivery and Storage
2026-08-17
This ChemRxiv preprint describes a ZIF-8 metal-organic framework strategy for encapsulating and delivering messenger RNA, with polyethyleneimine (PEI) added to reduce cargo leakage. The modified system supported protein expression in several cell lines and preserved functional mRNA after room-temperature storage, although the findings remain pre-peer-review and require broader validation.
-
Exo1 for Membrane Trafficking Assays
2026-08-17
Exo1 provides an acute, mechanistically distinct way to interrogate Golgi–ER traffic, ARF1 behavior, and secretion in cell-based workflows. Its value extends to tumor extracellular vesicle studies as a controlled trafficking perturbation, not as a selective TEV therapeutic.
-
Mitochondrial Repair in Diabetic Periodontitis
2026-08-16
The reference study develops an M1-macrophage-targeted, ROS-responsive hydrogel platform that delivers MitoQ to dysfunctional mitochondria in diabetic periodontitis. Its findings connect mitochondrial repair with reduced NLRP3 inflammasome activity, improved osteogenic responses, and enhanced periodontal bone regeneration, while also defining important questions for translation beyond the rat model.
-
Reserpine (N1867): Practical Lab Workflow
2026-08-15
Reserpine (SKU N1867) provides a defined research material for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology research. Its water and ethanol insolubility, DMSO compatibility, potent bioactivity, and limited solution stability require deliberate preparation and QC; it is not intended for diagnostic, therapeutic, or other medical use.
-
CD44 Metabolic Rewiring in IDH-Mutant Leukemia
2026-08-14
Lyu and colleagues identify CD44 as a functional metabolic dependency of IDH-mutant leukemia rather than merely an adhesion marker. Their data connect CD44 to pentose phosphate pathway activation, glycolysis suppression, NADPH production, and sustained R-2HG synthesis, supporting combined CD44 and mutant-IDH targeting as a strategy for overcoming incomplete responses.
-
Sodium Ascorbate and Biomarker-Aware ROS Models
2026-08-14
Sodium Ascorbate enables redox-focused cancer assays, but its value can extend beyond simple cytotoxicity measurements. This article develops a biomarker-aware framework that connects ROS experiments with GPNMB, tumor–immune context, and assay interpretation without overstating translational evidence.
-
Protein A/G Magnetic Co-IP/IP Kit for AP2-M
2026-08-13
Use magnetic Protein A/G capture to move from a candidate protein to a testable interaction network, with workflows suited to fragile complexes, antibody recovery, SDS-PAGE, and mass spectrometry. The approach also provides a practical bridge from the AP2-M regulatory findings in Babesia to protein-level validation.
-
UBR1 and UBR2: Mammalian ER Stress Sensors
2026-08-13
The reference study identifies the N-recognin E3 ligases UBR1 and UBR2 as previously underappreciated regulators of mammalian endoplasmic reticulum stress and protein quality control. Its findings connect stress-dependent stabilization of these proteins with protection from apoptosis, extending the N-degron pathway into ER-associated degradation biology.
-
ApexPrep DNA Plasmid Miniprep Kit for AML Workflows
2026-08-12
Build reliable plasmid DNA extraction for cloning, sequencing, and AML functional assays with one streamlined alkaline-lysis workflow. The ApexPrep DNA Plasmid Miniprep Kit supports high-copy and low-copy vectors while delivering up to 30 μg of molecular biology grade plasmid DNA from 1–5 mL cultures.
-
Annexin V-PE Reagent for CAR-T Apoptosis
2026-08-12
Use the Annexin V-PE Reagent to connect CAR binder design with practical measurements of target-cell apoptosis, effector-cell health, and fratricide. Its rapid phosphatidylserine readout supports both flow cytometry and fluorescence microscopy workflows, helping researchers distinguish early apoptotic signaling from later membrane failure.
-
Azithromycin: From Ribosome to Translation Strategy
2026-08-11
A translational framework for using Azithromycin in bacterial infection research, antibacterial drug resistance studies, impurity control, and trypanosomosis animal models—connecting ribosomal mechanism with experimental design and analytical discipline.
-
Acetylcholine Chloride in Gut-Brain Assays
2026-08-11
Acetylcholine Chloride provides a defined cholinergic challenge for separating receptor responsiveness from upstream microbiota, vagal, and neuronal effects. This practical workflow translates recent gut-brain findings into reproducible ex vivo, cellular, and neurophysiology assays while emphasizing concentration control, fresh solution handling, and appropriate experimental limits.
-
Vitamin C, NAC, and Cochlear Cell Senescence
2026-08-10
This 2024 study used a D-galactose-induced HEI-OC1 senescence model to show that vitamin C reduces oxidative, inflammatory, and senescence-associated changes in cochlear hair cells. N-acetylcysteine served as a redox-oriented comparator, supporting the interpretation that ROS/NF-κB pathway activity is involved, while also highlighting the limits of inferring pathway causality from a short-term cell model.
-
Sumatriptan Succinate: 5-HT1B Research Workflows
2026-08-09
Sumatriptan Succinate supports more than receptor pharmacology: it can connect 5-HT1B/1D signaling, neuroinflammation models, and enzyme-resolved metabolism assays. This workflow guide shows how to design concentration series, interpret CYP and MAO findings, and troubleshoot inconsistent cellular or LC-MS results.
-
Fulvestrant (ICI 182,780) Research Workflows
2026-08-08
Build reproducible ERα perturbation assays with Fulvestrant (ICI 182,780), from receptor degradation and MDM2 protein analysis to chemotherapy-sensitization studies. The workflow also translates a hemorrhagic-shock immunology study into carefully bounded assay choices without overstating cross-domain evidence.